Complete PSA Remission without Adjuvant Therapy after Secondary Lymph Node Surgery in Selected Patients with Biochemical Relapse after Radical Prostatectomy and Pelvic Lymph Node Dissection
Table 1
Summary of the patient characteristics.
Patient
Age (yr)
Primary treatment
Initial tumour stage
Gleason score
Hormonal therapy after primary treatment
Radiotherapy after primary treatment
PSA initial (ng/mL)
PSA1 (ng/mL)
PET/CT positive LN
1
61
RPE + PLND
pT3a pN0 cM0 R0
3 + 4
−
−
4.13
0.92
1
2
59
RPE + PLND
pT2c pN0 cM0 R0
4 + 3
+
−
26.7
4.09
1
3
64
RPE + Splnd + ePLND right
pT3a pN1 cM0 R0
4 + 3
−
−
16.0
2.45
1
4
68
RPE
pT3a pN0 cM0 R0
?
−
+
9.9
1.64
1
5
78
RPE + PLND
pT3b pN0 cM0 R0
3 + 4
−
−
3.2
1.62
1
6
59
RPE + PLND
pT3a pN0 cM0 R0
4 + 3
+
−
7.6
4.51
1
7
49
RPE + PLND
pT3b pN0 cM0 R0
4 + 5
−
−
4.0
0.67
1
8
61
RRP + PLND
pT3a pN0 cM0 R0
5 + 5
+
+
?
9.55
3
9
53
RRP + PLND
pT3a pN0 cM0 R1
4 + 4
−
+
36.0
3.54
1
10
75
RRP + sPLND
pT3a pN0 cM0 R1
4 + 3
−
+
5.94
3.77
1
11
55
RRP + PLND
pT3b pN1 cM0 R0
4 + 3
−
−
5.08
0.5
2
mean
62
3.02
PSA initial: PSA at primary diagnosis; PSA1: PSA at time of PET/CT diagnosis.
